Search Tag: tumour recurrence

2025 25 Feb

  Hepatocellular carcinoma (HCC) presents significant challenges in clinical management due to its high recurrence rates and variable prognosis. Key pathologic features, including microvascular invasion (MVI), poorly differentiated pathologic grade (poor PG) and satellite nodules (SNs), contribute to tumour progression and treatment resistance....Read more

2025 09 Feb

  Hepatocellular carcinoma (HCC) remains one of the most prevalent and deadly malignancies worldwide. Among patients with small late-recurrent HCC, choosing an optimal treatment strategy is critical to improving survival and maintaining quality of life. Traditionally, surgical resection (SR) has been the primary curative approach, but less invasive...Read more